Search

Search Constraints

You searched for: Author/Creator Cheung, Belamy B.

Search Results

2. Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN‐amplified neuroblastoma. Issue 7 (16th March 2020)

3. Glutathione biosynthesis is upregulated at the initiation of MYCN‐driven neuroblastoma tumorigenesis. Issue 6 (2nd March 2016)

4. High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients. Issue 2 (1st May 2016)

5. Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma. Issue 7 (17th November 2022)

6. MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma. Issue 1 (28th September 2015)

7. MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma. Issue 1 (28th September 2015)

9. Thymosin‐β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma. Issue 7 (29th April 2015)